Niva Bupa Health Insurance Company Limited
All news and filings related to Niva Bupa Health Insurance Company Limited.
View all news & filings- Low impact
Niva Bupa Appoints Karan Bhatia as New Chief Investment Officer
Niva Bupa Health Insurance announced changes in senior management effective September 16, 2026. Vikas Jain moves to Chief Transformation Officer. Karan Bhatia is appointed as the new Chief Investment Officer, bringing over 18 years of investment experience.
Read the summary - Low impact
Niva Bupa Health Insurance receives '67 Leader' ESG rating for FY25-26
Niva Bupa Health Insurance received an ESG rating of '67 Leader' for FY 2024-25 & FY 2025-26 from Niche99 ESG Ratings. The rating was assigned independently based on publicly available data.
Read the summary - Medium impact
Niva Bupa Health Insurance gets ICRA AAA issuer rating, AA+ for ₹500 Cr debt
Niva Bupa Health Insurance's Issuer Rating reaffirmed at [ICRA]AAA (Stable) by ICRA Limited. A rating of [ICRA]AA+(Stable) assigned to proposed subordinated debt of up to ₹500 crore via NCDs. Rating letters received on August 20, 2026.
Read the summary - Medium impact
Niva Bupa warned by IRDAI, restricted from opening new offices for 6 months
IRDAI has warned Niva Bupa for non-compliance with Expense of Management (EoM) limits for FY24-25. The company is restricted from opening new offices for six months from August 19, 2026. Niva Bupa asserts compliance for FY26 and Q1 FY27.
Read the summary - Low impact
Niva Bupa Health Insurance Holds 18th AGM on Aug 12, 2026
Niva Bupa Health Insurance held its 18th AGM on August 12, 2026. The meeting addressed financial statements for FY26 and approved director re-appointments and remuneration. Key appointments included Ashwani Bhatia as Independent Director and Siobhan Djihan Moynihan and Christopher Patrick Carroll as Non-Executive Directors.
Read the summary - Medium impact
Niva Bupa gets IRDAI nod for Ashwani Bhatia as Chairperson
Niva Bupa Health Insurance Company Limited has received IRDAI approval for the appointment of Mr. Ashwani Bhatia as Chairperson. The approval is effective from June 03, 2026, and was officially communicated by IRDAI on August 10, 2026.
Read the summary - High impact
Niva Bupa Q1 FY27: Profit Up, Retail Growth Strong, CISR Improves
Niva Bupa Health Insurance reported Q1 FY27 Profit After Tax of ₹137.8 crore and improved CISR to 100.2%. Retail health business saw strong growth of 47.1%, increasing market share to 11.1%. The company is transitioning to Ind AS and exploring debt raising up to ₹500 crore. Its solvency ratio is 2.25.
Read the summary - Low impact
Niva Bupa Health Insurance Publishes Unaudited Financial Results for Q1 FY27
Niva Bupa Health Insurance Company Limited published its unaudited financial results for the quarter ended June 30, 2026. The results were published in Financial Express and Jansatta on August 01, 2026. The Board approved the results on July 30, 2026.
Read the summary - Low impact
Niva Bupa Health Insurance Holds Earnings Call on Q1 FY27 Performance
Niva Bupa Health Insurance conducted an earnings call on July 30, 2026, to discuss performance for the quarter ended June 30, 2026. The audio recording of the call is available on the company's website.
Read the summary - High impact
Niva Bupa Q1 FY27 PAT ₹137.8 Cr, up 93%; GWP ₹2,150 Cr
Niva Bupa reported Q1'FY2027 PAT of ₹137.8 crore, a 93% increase from Q1'FY2026. GWP reached ₹2,150 crore, up 31.7% YoY. Retail Health GWP grew 47.1% to ₹1,607.1 crore, with market share at 11.1%. CISR improved to 100.2%. The company adopted Ind AS accounting standards and was recognized as a Great Place to Work.
Read the summary - Medium impact
Niva Bupa Health Insurance Approves ₹500 Crore Fundraise via NCDs
Niva Bupa Health Insurance approved its unaudited financial results for the quarter ended June 30, 2026. The company also sanctioned fundraising of up to ₹500 crores through the issuance of non-convertible debentures on a private placement basis.
Read the summary - Low impact
Niva Bupa Health Insurance to host Q1FY27 Earnings Conference Call on July 30, 2026
Niva Bupa Health Insurance will conduct its Q1FY27 earnings conference call on July 30, 2026, at 17:30 IST. The call will cover business performance for the quarter ending June 30, 2026. Key management, including the MD & CEO, will be present.
Read the summary - Low impact
Niva Bupa Health Insurance Announces 18th AGM and E-voting Details
Niva Bupa Health Insurance will hold its 18th AGM on August 12, 2026, via video conference. The AGM notice and annual report were dispatched on July 17, 2026. Remote e-voting is open from August 9 to August 11, 2026. The cut-off date for voting eligibility is August 5, 2026.
Read the summary - Low impact
Niva Bupa Health Insurance releases BRSR for FY 2025-26
Niva Bupa Health Insurance Company Limited has released its Business Responsibility and Sustainability Report for FY 2025-26. The report emphasizes the company's commitment to responsible business conduct, ESG, and CSR initiatives. The company operates as 100% paperless and has a paid-up capital of ₹1,84,746 lakhs.
Read the summary - Medium impact
Niva Bupa announces 18th AGM on Aug 12, 2026; to adopt FY26 results
Niva Bupa will hold its 18th AGM on August 12, 2026, to adopt FY26 financial statements. Key agenda items include re-appointing directors, approving auditor remuneration, and appointing Ashwani Bhatia as Independent Director. Remuneration revisions for MD Krishnan Ramachandran and other executives, including ESOP grants, will also be discussed.
Read the summary - Medium impact
Niva Bupa Health Insurance Assigned '[ICRA]AAA(Stable)' Issuer Rating
Niva Bupa Health Insurance Company Limited has received an Issuer Rating of '[ICRA]AAA(Stable)' from ICRA Limited. The rating was assigned on July 15, 2026, indicating a stable outlook for the company's financial stability and obligations.
Read the summary - Medium impact
Niva Bupa Receives ₹22.12 Crore Refund in GST Litigation
Niva Bupa Health Insurance Company Limited received a refund sanction order for ₹22.12 crores from the Deputy Commissioner of State Tax, Mumbai on July 14, 2026. This resolves a tax litigation concerning input tax credit disallowance for July 2017 to September 2022.
Read the summary - Low impact
Niva Bupa Health Insurance announces 18th AGM on Aug 12, 2026, via VC
Niva Bupa Health Insurance Company Limited will hold its 18th Annual General Meeting (AGM) on August 12, 2026, via Video Conferencing. The company will share the Notice of AGM and Annual Report electronically. Shareholders can participate and vote remotely or during the meeting.
Read the summary - Low impact
Niva Bupa Files SEBI Compliance Certificate for Q1 FY27
Niva Bupa Health Insurance Company Limited submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018. This filing covers the quarter ended June 30, 2026, and was received from the company's Registrar and Share Transfer Agent, KFin Technologies Limited.
Read the summary - Low impact
Niva Bupa Health Insurance's ₹250 Cr NCDs reaffirmed 'CARE AA Stable' rating
Niva Bupa Health Insurance's ₹250 crore Non-Convertible Debentures have been reaffirmed with a 'CARE AA Stable' rating by Care Ratings Limited. The company received this notification on June 22, 2026.
Read the summary - Medium impact
Niva Bupa Appoints Ashwani Bhatia as Independent Director, Chairman; Milind Barve Resigns
Niva Bupa Health Insurance announced the resignation of Director Milind Barve, effective June 02, 2026. Ashwani Bhatia has been appointed as an Additional Director and Chairperson, effective June 03, 2026, for a five-year term, subject to shareholder and IRDAI approvals.
Read the summary - Low impact
Niva Bupa Health Insurance Files Annual Secretarial Compliance Report for FY26
Niva Bupa Health Insurance Company Limited has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms compliance with SEBI regulations. A previous fine of ₹47,200 for delayed financial results submission was paid.
Read the summary - Low impact
Niva Bupa Allots 3.00 Lakh Equity Shares Under ESOP Scheme
Niva Bupa Health Insurance Company Limited allotted 3,00,500 equity shares under its ESOP Scheme 2020 on May 15, 2026. The face value of each share is ₹10. This increases the company's paid-up share capital to 1,84,77,57,271 equity shares.
Read the summary - High impact
Niva Bupa Health Insurance Q4 FY26 Earnings Call Transcript Released
Niva Bupa Health Insurance reported FY26 GWP of ₹9,433 crore, a 27.4% growth, with retail growth at 35%. Profit after tax surged to ₹366 crore from ₹203 crore, achieving a 10.7% ROE. Q4 FY26 profit grew 90% YoY. Market share in retail health reached 10.1% for FY26. The company aims for a 99% combined ratio by FY29.
Read the summary - Medium impact
Niva Bupa Health Insurance Files Audited Results for FY26 Ended March 31
Niva Bupa Health Insurance has published its audited financial results for the quarter and year ended March 31, 2026. For FY26, premium income was ₹8,58,592 lakhs, with a net profit after tax of ₹13,078 lakhs. For Q4 FY26, premium income was ₹2,87,968 lakhs and net profit after tax was ₹34,513 lakhs.
Read the summary - Low impact
Niva Bupa Health Insurance posts Q4 FY26 results; earnings call recording available
Niva Bupa Health Insurance Company Limited hosted an earnings call on May 08, 2026, to discuss its performance for the quarter and financial year ended March 31, 2026. The audio recording of this call is now available on the company's website.
Read the summary - Medium impact
Niva Bupa Appoints Two Directors, Promotes Ankur Kharbanda, Grants ESOPs
Niva Bupa appointed Mr. Christopher Patrick Carroll and Ms. Siobhan Djihan Moynihan as Additional Directors, effective May 15, 2026. Mr. Ankur Kharbanda was promoted to Executive Director and Deputy CEO, effective May 08, 2026. The company granted 12,251,268 ESOPs at ₹72.45 per option. Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo resigned as Non-Executive Directors.
Read the summary - Medium impact
Niva Bupa Appoints 2 Directors, Elevates Ankur Kharbanda, Grants ESOPs
Niva Bupa appointed Christopher Patrick Carroll and Siobhan Djihan Moynihan as Additional Directors, effective May 15, 2026. Ankur Kharbanda was elevated to Executive Director and Deputy CEO, effective May 08, 2026. The company also granted 12,251,268 ESOPs at ₹72.45 per option. Penelope Ruth Dudley and Carlos Antonio Jaureguizar Ruiz-Jarabo resigned as Non-Executive Directors.
Read the summary - Medium impact
Niva Bupa Appoints Two Directors, Elevates Ankur Kharbanda, Grants ESOPs
Niva Bupa appointed Christopher Patrick Carroll and Siobhan Moynihan as Non-Executive Directors from May 15, 2026. Ankur Kharbanda was elevated to Executive Director and Deputy CEO from May 08, 2026. The company also granted 12,251,268 ESOPs. Resignations of two Non-Executive Directors were accepted.
Read the summary - Medium impact
Niva Bupa Appoints Two Directors, Elevates Ankur Kharbanda, Grants ESOPs
Niva Bupa appointed Christopher Patrick Carroll and Siobhan Djihan Moynihan as Non-Executive Directors from May 15, 2026. Ankur Kharbanda was elevated to Executive Director and Deputy CEO from May 08, 2026. The company granted 12,251,268 ESOPs at ₹72.45 each. Penelope Ruth Dudley and Carlos Antonio Jaureguizar Ruiz-Jarabo resigned as Non-Executive Directors on May 08, 2026.
Read the summary - Medium impact
Niva Bupa Appoints Two Directors, Elevates Ankur Kharbanda, Grants ESOPs
Niva Bupa appointed Christopher Patrick Carroll and Siobhan Djihan Moynihan as Additional Directors (Non-Executive) from May 15, 2026. Ankur Kharbanda was elevated to Executive Director & Deputy CEO from May 08, 2026. The company also approved granting 12,251,268 ESOPs at ₹72.45 per option. Penelope Ruth Dudley and Carlos Antonio Jaureguizar Ruiz-Jarabo resigned as Non-Executive Directors effective May 08, 2026.
Read the summary - High impact
Niva Bupa FY26 PAT Surges 80% to ₹366 Cr; GWP Grows 27% to ₹8,586 Cr
Niva Bupa reported strong FY26 results with PAT growing 80% to ₹366 crore and GWP increasing 27% to ₹8,586 crore. Market share rose to 10.1%, and the claim settlement ratio improved to 94.4%. Q4FY26 GWP grew 39% to ₹2,880 crore. The company aims for sustainable profitability with improved CISR.
Read the summary - High impact
Niva Bupa FY26 PAT ₹366 Cr, GWP ₹9,433 Cr; Retail Health Share 10.1%
Niva Bupa Health Insurance reported FY2026 GWP of ₹9,432.9 crore, up 27.4% YoY. PAT surged to ₹366 crore from ₹203 crore in FY2025. Retail Health market share grew to 10.1% from 9.4%. The company emphasizes its technology-driven model and improved customer service, with Weighted Episodal NPS at 60.
Read the summary - Medium impact
Niva Bupa Health Insurance Reports Audited Financials for FY26; EOM Ratio Improves
Niva Bupa Health Insurance's Board approved audited financial results for FY26 and Q4FY26. The company reported an improved Expenses of Management (EOM) ratio of 28.49% for the quarter and 33.70% for the year ended March 31, 2026, adhering to regulatory guidelines. Auditors issued an unmodified opinion on the financial statements.
Read the summary - Medium impact
Niva Bupa Health Insurance Reports Audited Financials for FY26
Niva Bupa Health Insurance announced audited financial results for FY26. For the quarter ended March 31, 2026, Gross Premium Written was ₹2,87,968 Lakhs and Net Premium Written was ₹2,30,166 Lakhs. For the full year, Gross Premium Written was ₹6,76,223 Lakhs and Net Premium Written was ₹5,36,943 Lakhs. The company reported a profit before tax of ₹34,116 Lakhs for the quarter and ₹6,022 Lakhs for the year. Auditors M/s. S.R. Batliboi & Co. LLP and M/s. Nangia & Co. LLP issued an unmodified opinion.
Read the summary - Low impact
Niva Bupa Health Insurance to host Analyst Call on May 8, 2026, for Q4FY26 results
Niva Bupa Health Insurance will hold an Earnings Conference Call on May 8, 2026, at 18:30 IST. The call will focus on the company's performance for the quarter and financial year ended March 31, 2026. Management including MD & CEO and CFO will be present.
Read the summary - Medium impact
Niva Bupa Health Insurance Gets IRDAI Nod for Investor Share Transfer
Niva Bupa Health Insurance received IRDAI approval on April 10, 2026, for the transfer of up to 14,62,02,091 equity shares by existing investor Fettle Tone LLP. The approval aligns with the Insurance Act, 1938, and IRDAI regulations.
Read the summary - Low impact
Niva Bupa files SEBI Reg 74(5) certificate for Q4FY26, no demat requests processed
Niva Bupa Health Insurance Company Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended March 31, 2026. Registrar KFin Technologies confirmed no demat requests were processed as shares are not held in physical form.
Read the summary - Low impact
Niva Bupa Health Insurance Closes Trading Window for FY26 Results
Niva Bupa Health Insurance's trading window closes from April 1, 2026, for designated persons. It will reopen 48 hours after the Q4 and FY26 audited financial results are announced. The board meeting date for result consideration will be announced later.
Read the summary - Medium impact
Niva Bupa Shareholders Approve Director Appointment and CEO Remuneration Revision
Niva Bupa Health Insurance Company Limited shareholders approved the appointment of Mr. Roger William John Davis as Non-Executive Director and a revision in remuneration for MD & CEO Mr. Krishnan Ramachandran. Both resolutions passed with 99.99% majority via postal ballot on March 26, 2026.
Read the summary - Low impact
Niva Bupa to Participate in Investor Meet Organized by ICICI Securities on March 30
Niva Bupa Health Insurance Company Limited representatives will attend an investor meet organized by ICICI Securities. The group meeting is scheduled for March 30, 2026, at the Grand Hyatt, Mumbai. No unpublished price-sensitive information will be disclosed.
Read the summary - Medium impact
Niva Bupa faces ₹28.37 Cr Income Tax demand for AY 2023-24
Niva Bupa Health Insurance Company Limited received an Income Tax demand of ₹28.37 crore for AY 2023-24, including ₹7.10 crore interest. The demand is due to disallowances on marketing expenses and IBNR/IBNER provisions. The company plans to appeal the order.
Read the summary - Low impact
Niva Bupa Allots 2,58,200 Equity Shares Under ESOP Scheme 2020
Niva Bupa Health Insurance Company Limited allotted 2,58,200 equity shares on March 05, 2026, under its ESOP Scheme 2020. The shares have a face value of ₹10 each and will rank pari-passu with existing equity shares.
Read the summary - Medium impact
Niva Bupa receives Letter of Advice from IRDAI; no financial impact.
Niva Bupa Health Insurance Company Limited received a Letter of Advice and a Show Cause Notice from IRDAI on February 26, 2026. The company is responding to both and implementing recommended actions. No financial or operational impact is expected at this time.
Read the summary - Low impact
Niva Bupa Health Insurance Co. Ltd. Publishes Newspaper Advertisement for Postal Ballot Notice
Niva Bupa Health Insurance Company Limited has published newspaper advertisements for its Postal Ballot Notice. The e-voting period for members to cast their votes on resolutions will be from February 25, 2026, to March 26, 2026. Results are expected by March 28, 2026.
Read the summary - Medium impact
Niva Bupa seeks shareholder approval for Director appointment and CEO remuneration revision
Niva Bupa is seeking shareholder approval via postal ballot for the appointment of Mr. Roger William John Davis as a Non-Executive Director and a revision in the remuneration of MD & CEO Mr. Krishnan Ramachandran for FY25-26. The revised remuneration includes fixed pay and projected bonuses (cash and ESOPs). E-voting period: February 25, 2026, to March 26, 2026.
Read the summary - Low impact
Niva Bupa to Participate in Kotak Securities Investor Conference on Feb 24
Niva Bupa Health Insurance Company Limited representatives will attend the Kotak Securities - Chasing Growth 2026 Conference in Mumbai on February 24, 2026. No unpublished price-sensitive information will be shared. The participation is subject to change.
Read the summary - Medium impact
Niva Bupa Q3 FY'26 Earnings Call Transcript Released
Niva Bupa released its Q3 FY'26 earnings call transcript. The company reported a 74% year-on-year increase in PAT to ₹208 crores for the nine months ended Dec 31, 2025. Overall growth was 26%, with retail growth at 33%. Market share improved to 10%. The direct digital channel saw 70% growth in Q3.
Read the summary - Low impact
Niva Bupa Health Insurance Files Unaudited Financial Results for Q3 FY26
Niva Bupa Health Insurance Company Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. For the quarter, Premium Income was ₹2,23,127 lakhs and Net Loss after tax was ₹(8,764) lakhs. For the nine months, Premium Income was ₹5,70,625 lakhs and Net Loss after tax was ₹(21,435) lakhs.
Read the summary - Low impact
Niva Bupa Health Insurance Releases Q3 FY26 Earnings Call Recording
Niva Bupa Health Insurance released the audio recording of its earnings conference call held on January 29, 2026. The call focused on the company's performance for the quarter and nine months ending December 31, 2025. The recording is available on the company's investor relations website.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio